HCV – Source Patient Identification and Group Overlap Treatment
Funded by: Gilead - Conquering Hepatitis via Micro-Elimination (CHIME)
Project dates: May 2019 - December 2021
Principal Investigator: Eckhardt, Benjamin

This proof-of-concept study aimed to evaluate a partner services case findings and treatment strategy to achieve injection network level hepatitis C micro-elimination.

After identification of incident HCV infection the partner services model included:

  1. Evaluation of the incident infections injection network utilizing proximal partner identification
  2. Incentivized partner linkage and screening
  3. Transmission root evaluation utilizing next-generation HCV sequencing, and
  4. Injection network overlap treatment.